MBX DCF Valuation - MBX Biosciences Inc

M

Watchlist Manager

Watchlist

Price: 27.82 USD -1.14% Market Closed

Market Cap: $1.3B

M	MBX Biosciences Inc NASDAQ:MBX	US
G	Grindr Inc NYSE:GRND	US
	Cincinnati Financial Corp NASDAQ:CINF	US
C	Chrysos Corp Ltd ASX:C79	AU
	M&G PLC LSE:MNG	UK
	Russel Metals Inc TSX:RUS	CA
	Saputo Inc TSX:SAP	CA
	Sangoma Technologies Corp TSX:STC	CA
	TVS Electronics Ltd NSE:TVSELECT	IN
	Nhoa SA PAR:NHOA	FR
	Re/Max Holdings Inc NYSE:RMAX	US
	Ramsay Health Care Ltd ASX:RHC	AU
	Gawk Inc OTC:GAWK	US
	Calima Energy Ltd ASX:CE1	AU
	Chip Eng Seng Corporation Ltd SGX:C29	SG
	Gunosy Inc TSE:6047	JP
	Hub24 Ltd ASX:HUB	AU
B	Bleach Inc TSE:9162	JP
I	Interworld Digital Ltd BSE:532072	IN
	Mathew Easow Research Securities Ltd BSE:511688	IN
	Gelsenwasser AG F:WWG	DE
L	Larsen & Toubro Ltd OTC:LTOUF	IN
W	Winfull Group Holdings Ltd HKEX:183	HK
	Core Scientific Inc NASDAQ:CORZ	US

MBX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.